| INVENTIVA ADR |
| USA |
| Gesundheit |
| US46124U1079 / A2P796 |
| 6IVA (Frankfurt) / IVA (NASDAQ) |
| FRA:6IVA, ETR:6IVA, 6IVA:GR, NASDAQ:IVA |
| - |
| https://inventivapharma.c.. |
|
Inventiva S.A. is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. With its research and development headquarters situated in France, the company dedicates its efforts to designing treatments for..
>Volltext.. |
| 949.44 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| INVENTIVA ADR, INVENTIVA |
| 05.04.26 |
|
||||
|